These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 27811377

  • 1. Correlation between serum IL-1β and miR-144-3p as well as their prognostic values in LUAD and LUSC patients.
    Wu C, Xu B, Zhou Y, Ji M, Zhang D, Jiang J, Wu C.
    Oncotarget; 2016 Dec 27; 7(52):85876-85887. PubMed ID: 27811377
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
    Petkova V, Marinova D, Kyurkchiyan S, Stancheva G, Mekov E, Kachakova-Yordanova D, Slavova Y, Kostadinov D, Mitev V, Kaneva R.
    Medicine (Baltimore); 2022 Aug 19; 101(33):e30027. PubMed ID: 35984198
    [Abstract] [Full Text] [Related]

  • 5. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B, Chen Y, Yang J.
    Oncotarget; 2017 Apr 11; 8(15):24275-24291. PubMed ID: 27903974
    [Abstract] [Full Text] [Related]

  • 6. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL, Gong Y, Zhao DP.
    Eur Rev Med Pharmacol Sci; 2018 Dec 11; 22(24):8731-8739. PubMed ID: 30575913
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY, Liu CH, Xue Y, Chen YY, Wang YL, Wu XZ.
    Gene; 2020 Mar 10; 730():144316. PubMed ID: 31884109
    [Abstract] [Full Text] [Related]

  • 8. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N, Li Y, Zheng P, Zhan X.
    Front Endocrinol (Lausanne); 2021 Mar 10; 12():755805. PubMed ID: 34745015
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
    Meng F, Zhang L, Ren Y, Ma Q.
    J Cell Physiol; 2019 Jul 10; 234(7):10918-10925. PubMed ID: 30549039
    [Abstract] [Full Text] [Related]

  • 12. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z, He J.
    Cancer Lett; 2017 May 01; 393():40-51. PubMed ID: 28223168
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X, Chen L, Zhang T.
    Cancer Control; 2018 May 01; 25(1):1073274818778001. PubMed ID: 29843532
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma.
    Li L, Liu YD, Zhan YT, Zhu YH, Li Y, Xie D, Guan XY.
    Thorac Cancer; 2018 Jul 01; 9(7):775-784. PubMed ID: 29722145
    [Abstract] [Full Text] [Related]

  • 18. Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma.
    Xu X, Zhang J, Yao T, Zhao X, Wu Q, Lu C, Guo X, Xie S, Qiu L, Bi R, Xue H.
    Int Immunopharmacol; 2024 Sep 30; 139():112727. PubMed ID: 39067405
    [Abstract] [Full Text] [Related]

  • 19. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.
    Ren K, Yu Y, Wang X, Liu H, Zhao J.
    Life Sci; 2021 Jun 01; 274():119330. PubMed ID: 33711383
    [Abstract] [Full Text] [Related]

  • 20. Comprehensive analysis of aberrantly expressed microRNA profiles reveals potential biomarkers of human lung adenocarcinoma progression.
    Sui J, Yang RS, Xu SY, Zhang YQ, Li CY, Yang S, Yin LH, Pu YP, Liang GY.
    Oncol Rep; 2017 Oct 01; 38(4):2453-2463. PubMed ID: 28791371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.